Related Experiment Video

Updated: Feb 5, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K

Dabrafenib and its use in the treatment of metastatic melanoma

Samantha Bowyer1,1, Rebecca Lee1,1, Alberto Fusi1,1

  • 1Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.

Melanoma Management
|September 8, 2018
PubMed

Insights

Targeted therapies like dabrafenib (a BRAF inhibitor) and trametinib (a MEK inhibitor) show high response rates and improved survival for metastatic melanoma patients with BRAF mutations. Combination therapy offers superior efficacy over monotherapy.

Area of Science:

  • Oncology
  • Pharmacology
  • Genetics

Background:

  • Approximately 50% of melanomas harbor mutations in the BRAF gene.
  • Targeted therapies have revolutionized metastatic melanoma treatment.
  • BRAF inhibitors offer improved survival outcomes compared to traditional chemotherapy.

Purpose of the Study:

  • To summarize the pharmacology of dabrafenib, a BRAF kinase inhibitor.
  • To review key clinical trial data for dabrafenib, alone and in combination with trametinib.
  • To discuss practical clinical experience and future directions for BRAF-mutated melanoma treatment.

Main Methods:

  • Review of pharmacology and clinical trial data for dabrafenib and trametinib.
  • Analysis of response rates, progression-free survival, and overall survival.
  • Evaluation of toxicity profiles compared to chemotherapy.

Main Results:

  • Dabrafenib demonstrates high response rates and rapid onset of action in BRAF-mutated melanomas.
  • Combination therapy with dabrafenib and trametinib shows superior clinical efficacy and response rates compared to monotherapy.
  • Toxicity associated with these targeted therapies is distinct from chemotherapy but manageable.

Conclusions:

  • Dabrafenib, particularly in combination with trametinib, represents a significant advancement in treating metastatic melanoma with BRAF mutations.
  • These targeted therapies offer improved survival benefits over chemotherapy.
  • Continued clinical experience and research are essential for optimizing treatment strategies.
Keywords:
BRAFV600dabrafenibmetastatic melanoma

More Related Videos

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs07:31

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs

Published on: May 24, 2016

18.2K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
959
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K